Maternal and neonatal outcomes following methadone substitution during pregnancy

Archives of Gynecology and Obstetrics

Volumn 286, Issue 4, 2012, Pages 843-851

  Greig, Emma ^a   Ash, Alok ^b   Douiri, Abdel ^c  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Methadone substitution programme; Neonatal abstinence syndrome; Perinatal outcome; Substance misuse

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BIRTH WEIGHT; BODY MASS; CLINICAL ARTICLE; EMPLOYMENT STATUS; ETHNICITY; FEMALE; HEAD CIRCUMFERENCE; HUMAN; MATERNAL CARE; METHADONE TREATMENT; NEWBORN CARE; OUTCOME ASSESSMENT; PREGNANCY; PREGNANT WOMAN; SMOKING; HEROIN DEPENDENCE; NEWBORN; OPIATE SUBSTITUTION TREATMENT; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; RETROSPECTIVE STUDY; UNITED KINGDOM; WITHDRAWAL SYNDROME;

METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESICS, OPIOID; FEMALE; GREAT BRITAIN; HEROIN DEPENDENCE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; METHADONE; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84873464409     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2372-9     Document Type: Article

References (26)

1. Kraus L, Augustin R, Frischer M, Kummler P, Uhl A, Wiessing L (2003) Estimating the prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction 98:471-485
2. Department of Health (England) and the Devolved Administrations (2007) Drug misuse and dependence: UK guidelines on clinical management. Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive, London. The Stationary Office, London
3. Clarke K, Formby J (2000) Feeling good, doing fine. Druglink 15:10-13
4. Fajemirokun-Odudeyi O, Sinha C, Tutty S, Pairaudeau P, Armstrong D, Phillips T, Lindow SW (2005) Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol 126:170-175
5. Day E, George S (2005) Management of drug misuse in pregnancy. Adv Psychiatric Treat 11:253-261
6. Hulse GK, Milne E, English DR, Holman CDJ (1997) The relationship between maternal use of heroin and methadone in infant birth weight. Addiction 92:1571-1579
7. Little BB, Snell LM, Klein VR, Gistrap LC 3rd, Knoll KA, Breckenridge JD (1990) Maternal and fetal effects of heroin addiction during pregnancy. J Reprod Med 35:159-162
8. Finnegan LP, Kron RE, Connaughton JF, Emich JP (1975) Assessment and treatment of abstinence in the infant of the drug dependant mother. Int J Clin Pharmacol Biopharm 12(1-2):19-32
9. Osborn DA, Jeffery HE, Cole M (2005) Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev (3):CD002059. doi:10.1002/14651858.CD002059.pub2 (Citation as instructed)
10. Kashiwagi M, Arlettaz R, Lauper U, Zimmermann R, Hebisch G (2005) Methadone maintenance program in a Swiss perinatal center: (I): management and outcome of 89 pregnancies. Acta Obstet Gynecol Scand 84(2):140-144
11. Ward J, Mattick RP, Hall W (1998) Methadone maintenance during pregnancy. In:Ward J,Mattick RP, HallW(eds)Methadone maintenance treatment and other opioid replacement therapies. Harwood Academic Publishers, Amsterdam, pp 397-418
12. Llewelyn RW (2000) Substance abuse in pregnancy: the team approach to antenatal care. Obstet Gynaecol 2(1):11-16
13. Hepburn M (1997) Drugs of addiction. In: Cockburn F (ed) Advances in perinatal medicine. Parthenon Publishing, Carnforth, London
14. Minozzi S, Amato L, Vecchi S, Davoli M (2008) Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev (2):CD006318. doi:10.1002/14651858. CD006318.pub2
15. Greater London Alcohol and Drug Alliance (GLADA) (2005). Alcohol and drugs in London: improving the options for women.Greater London Authority, London. http://legacy.london. gov.uk/mayor/health/docs/womens_report.pdf
16. Management of opioid drug users/methadone programme patients, April 2009. Guy's and St. Thomas' Hospitals NHS Foundation Trust, London
17. (2008) Guidelines for the woodvine maternity liaison service (North): a joint substance misuse service between South London & Maudsley and Guys & St Thomas' Foundation NHS Trusts, March 2008
18. Boer K, Smith BJ, van Huis AM, Hogerzeil HV (1994) Substance use in pregnancy: do we care? Acta Paediatr 83(s404):65-71
19. Kakko J, Heilig M, Sarman I (2008) Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend 1:69-78
20. Kuschel C (2007) Managing drug withdrawal in the newborn infant. Semin Fetal Neonat Med 12:127-133
21. Jansson LM, Velez M (2012) Neonatal abstinence syndrome. Curr Opin Pediatr 24(4):252-258
22. (2010) Effects of maternal active and passive on fetal and reproductive health: Royal College of Physicians, 11 St Andrews Place, London NW1 4LE, March 2010. http://www.rcplondon. ac.uk
23. (2004) Centre for disease control and prevention (CDC): CDC morbidity and mortality weekly report (MMWR: October 8, 2004). Smoking during pregnancy, United States, 1990-2002, vol 3, no 39, pp 911-915
24. (2010) National institute for health and clinical excellence (NICE): quitting smoking in pregnancy and following childbirth (PH26), Public Health Guidance PH26, June 2010. http://guidance.nice.org.uk/PH26
25. Yerushalmy J (1971) The relationship of parents' cigarette smoking to outcome of pregnancy-implications as to the problem of inferring causation from observed associations. Am J Epidemiol 93:443-456
26. Beckman C, Demilew J (2001) Audit of 'unbooked women' in maternity services, 2000. King's College Hospital, London